PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-gamma coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-alpha, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-alpha. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is elevated in liver in mouse models of diabetes and regulates the expression of TRB3, an inhibitor of insulin-dependent AKT activation [87, 88].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [88]
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“jpg" NDATA ITEM> ]> Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscl”
BackgroundWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“Despite its importance in promoting mitochondrial function in skeletal muscl”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649 · cited 1×
“The hypoglycemic fatty liver phenotype in PGC-1 knockdown mice is reminiscent of the phenotype of PPAR-α-deficient mice, which have hepatic steatosis and hypoglycemi”
BackgroundCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400 · cited 1×
“Overexpression of PPAR-α and its heterodimeric partner RX”
BackgroundSelf-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 1×
“Free fatty acids are thought to inhibit glucose us”
BackgroundMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“Both TRB-3 mRNA and PGC-1 mRNA were elevated in LIRKO mice, which have a knockout of the insulin receptor in live”
BackgroundSelf-citationTen years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177 · cited 1×
“In the fed state, insulin inhibits hepatic glucose output through a cascade of phospholipid-dependent kinases that activate Akt/PKB by phosphorylating it at Thr308 and Ser473 (refs”
Background
Cited by
Items 101–200 of 552
Yokoyama, T., & Nakamura, T. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01914.x · Cited by 163
Noland, R. C., Thyfault, J. P., Henes, S. T., Whitfield, B. R., Woodlief, T. L., Evans, J. R., Lust, J. A., Britton, S. L., Koch, L. G., Dudek, R. W., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00500.2006 · Cited by 140
Regulation of the Akt kinase by interacting proteins
Du, K., & Tsichlis, P. N. (2005) · Oncogene · doi:10.1038/sj.onc.1209099 · Cited by 159
“More important, whereas hepatic overexpression of TRB3 in amounts comparable to those in db/db mice induced glucose intolerance and hyperglycemia (Du et al., 2003), knocking down TRB3 expression with RNAi in the liver of db/db mice, restored insulin responsiveness (Koo et al., 2004).”
BackgroundDissociating fatty liver and diabetes
Sun, Z., & Lazar, M. A. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.09.005 · Cited by 136
Kim, D.-K., Ryu, D., Koh, M., Lee, M.-W., Lim, D., Kim, M.-J., Kim, Y.-H., Cho, W.-J., Lee, C.-H., Park, S. B., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315168 · Cited by 134
“Culture of Primary Hepatocytes—Primary hepatocytes were isolated from Sprague-Dawley rats (male, 180–300 g) by collagenase perfusion (28) and seeded with Medium 199 (Cellgro).”
MethodSelf-citationLi, M., Zeng, T., Liu, R., & Chen, L. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbt027 · Cited by 155
TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model
Ti, Y., Xie, G.-L., Wang, Z.-H., Bi, X.-L., Ding, W.-Y., Wang, J., Jiang, G.-H., Bu, P.-L., Zhang, Y., Zhong, M., et al. (2011) · Diabetes · doi:10.2337/db11-0549 · Cited by 143
“Tribbles 3 (TRB3) is a pseudokinase with increased activity in response to fasting that binds to and inhibits the activation of the serine-threonine kinase Akt in the liver (7,8).”
BackgroundResultChen, M., Gavrilova, O., Zhao, W.-Q., Nguyen, A., Lorenzo, J., Shen, L., Nackers, L., Pack, S., Jou, W., & Weinstein, L. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24196 · Cited by 141
Wang, C., Xu, C.-X., Krager, S. L., Bottum, K. M., Liao, D.-F., & Tischkau, S. A. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1103593 · Cited by 136
Metabolic control through glucocorticoid hormones: An update
Rose, A. J., & Herzig, S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.007 · Cited by 145
Self-citationEffects of Wnt Signaling on Brown Adipocyte Differentiation and Metabolism Mediated by PGC-1α
Kang, S., Bajnok, L., Longo, K. A., Petersen, R. K., Hansen, J. B., Kristiansen, K., & MacDougald, O. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1272-1282.2005 · Cited by 137
“Expression and activity of PGC-1 play important roles in regulating cellular respiration in numerous tissues, and PGC-1 may influence insulin sensitivity in liver and muscle ( 29 , 39).”
BackgroundPGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis
Estall, J. L., Ruas, J. L., Choi, C. S., Laznik, D., Badman, M., Maratos-Flier, E., Shulman, G. I., & Spiegelman, B. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912533106 · Cited by 134
Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis
Rodgers, J. T., Haas, W., Gygi, S. P., & Puigserver, P. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.006 · Cited by 129
“Notably, knockdown of PGC-1a in livers of db/db mice is sufficient to significantly reduce blood glucose levels (Koo et al., 2004), suggesting that hyperactivity of hepatic PGC-1a is a major defect in this insulin-resistant model.”
BackgroundMethodCui, A., Fan, H., Zhang, Y., Zhang, Y., Niu, D., Liu, S., Liu, Q., Ma, W., Shen, Z., Shen, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci66062 · Cited by 142
Cheng, K. K. Y., Iglesias, M. A., Lam, K. S. L., Wang, Y., Sweeney, G., Zhu, W., Vanhoutte, P. M., Kraegen, E. W., & Xu, A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.013 · Cited by 133
“Elevated TRB3 expression has previously been implicated as a mediator of insulin desensitization in the liver tissue of db/db obese mice (Du et al., 2003) as well as in several other insulinresistant conditions (He et al., 2006; Koo et al., 2004).”
BackgroundInfluentialThe Role of Catechins in Regulating Diabetes: An Update Review
Wen, L., Wu, D., Tan, X., Zhong, M., Xing, J., Li, W., Li, D., & Cao, F. (2022) · Nutrients · doi:10.3390/nu14214681 · Cited by 144
“The PGC-1α family, which is involved in mitochondrial biogenesis, has been found to suppress insulin secretion in both mice [73] and patients with T2D [74,75].”
BackgroundA high-selenium diet induces insulin resistance in gestating rats and their offspring
Zeng, M.-S., Li, X., Liu, Y., Zhao, H., Zhou, J.-C., Li, K., Huang, J.-Q., Sun, L.-H., Tang, J.-Y., Xia, X.-J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.017 · Cited by 128
“Many in vitro and in vivo studies have illustrated that dysregulated expression, localization, and/or activity of any of those proteins may result in insulin resistance [20,23–26].”
BackgroundThe Drosophila PGC‐1 homologue Spargel coordinates mitochondrial activity to insulin signalling
Tiefenböck, S. K., Baltzer, C., Egli, N., & Frei, C. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.330 · Cited by 141
“Although flies and mammals are several hundred millions apart in evolution, Spargel and its mammalian counterparts PGC-1a, PGC1-1b and PRC have conserved functions in respect to mitochondria and insulin signalling.”
BackgroundInfluentialPGC-1α affects skeletal muscle and adipose tissue development by regulating mitochondrial biogenesis
Kong, S., Cai, B., & Nie, Q. (2022) · Molecular Genetics and Genomics · doi:10.1007/s00438-022-01878-2 · Cited by 143
Signalling mechanisms linking hepatic glucose and lipid metabolism
Weickert, M. O., & Pfeiffer, A. F. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0295-3 · Cited by 127
“PPARα, the predominantly expressed form in the liver [55, 56], is involved in promoting gluconeogenesis [57, 58 ] and stimulates the transcription of genes that are critical for peroxisomal and mitochondrial oxidation of fatty acids [55].”
BackgroundSpeckmann, B., Walter, P. L., Alili, L., Reinehr, R., Sies, H., Klotz, L.-O., & Steinbrenner, H. (2008) · Hepatology · doi:10.1002/hep.22526 · Cited by 127
Hepatic transcriptional responses to fasting and feeding
Bideyan, L., Nagari, R., & Tontonoz, P. (2021) · Genes & Development · doi:10.1101/gad.348340.121 · Cited by 126
“While PGC-1α deficiency increases insulin sensitivity, PGC-1α overexpression causes insulin resistance (Koo et al. 2004; Leone et al. 2005; Liang et al. 2009).”
BackgroundLiew, C. W., Bochenski, J., Kawamori, D., Hu, J., Leech, C. A., Wanic, K., Malecki, M., Warram, J. H., Qi, L., Krolewski, A. S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36849 · Cited by 126
Self-citationBesse-Patin, A., Jeromson, S., Levesque-Damphousse, P., Secco, B., Laplante, M., & Estall, J. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815150116 · Cited by 124
Novel Small-Molecule PGC-1α Transcriptional Regulator With Beneficial Effects on Diabetic db/db Mice
Zhang, L., Zhou, H., Fu, Y., Li, Y., Wu, F., Gu, M., Wu, L., Xia, C.-M., Dong, T., Li, J.-Y., et al. (2013) · Diabetes · doi:10.2337/db12-0703 · Cited by 132
Diabetes Mellitus, Mitochondrial Dysfunction and Ca2+-Dependent Permeability Transition Pore
Belosludtsev, K. N., Belosludtseva, N. V., & Dubinin, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186559 · Cited by 127
Houten, S. M., & Auwerx, J. H. (2004) · Cell · doi:10.1016/j.cell.2004.09.016 · Cited by 134
“In view of this, the role of PGC-1 and othergenesis leading to fasting hypoglycemia (Koo et al., 2004).”
BackgroundMetabolic crosstalk between choline/1-carbon metabolism and energy homeostasis
Zeisel, S. H. (2013) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm-2012-0518 · Cited by 116
Separation of the gluconeogenic and mitochondrial functions of PGC-1α through S6 kinase
Lustig, Y., Ruas, J. L., Estall, J. L., Lo, J. C., Devarakonda, S., Laznik, D., Choi, J. H., Ono, H., Olsen, J. V., & Spiegelman, B. M. (2011) · Genes & Development · doi:10.1101/gad.2054711 · Cited by 116
“…most or all of the hepatic gene programs associated with fasting: gluconeogenesis, heme biosynthesis, fatty acid oxidation, and mitochondrial electron transport (Herzig et al. 2001; Yoon et al. 2001; Puigserver et al. 2003; Rhee et al. 2003; Koo et al. 2004; Handschin et al. 2005; Wu et al. 2009).”
BackgroundCharacterization of human NIPK (TRB3, SKIP3) gene activation in stressful conditions
Örd, D., & Örd, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.149 · Cited by 117
Fu, Q., McKnight, R. A., Yu, X., Wang, L., Callaway, C. W., & Lane, R. H. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00175.2004 · Cited by 114
Liang, J., Liu, C., Qiao, A., Cui, Y., Zhang, H., Cui, A., Zhang, S., Yang, Y., Xiao, X., Chen, Y., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.024 · Cited by 119
“Adenovirus-mediated knockdown of PGC-1a in db/db diabetic mouse livers decreases circulating glucose levels and improves glucose tolerance [15].”
BackgroundTribbles 3 mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle
Koh, H.-J., Toyoda, T., Didesch, M. M., Lee, M.-Y., Sleeman, M. W., Kulkarni, R., Musi, N., Hirshman, M. F., & Goodyear, L. J. (2013) · Nature Communications · doi:10.1038/ncomms2851 · Cited by 122
Self-citationMonsalve, M., & Olmos, Y. (2011) · Current Drug Targets · doi:10.2174/138945011796150307 · Cited by 124
“[335] Koo SH, Satoh H, Herzig S, et al.”
BackgroundSung, H. Y., Guan, H., Czibula, Á., King, A. R., Éder, K., Heath, E., Suvarna, S. K., Dower, S., Wilson, A. G., Francis, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610792200 · Cited by 112
Kim, B., Farruggia, C., Ku, C. S., Pham, T. X., Yang, Y. J., Bae, M., Wegner, C., Farrell, N., Harness, E., Park, Y., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.01.006 · Cited by 122
“peroxisomal fatty acid oxidation in skeletal muscle [71-76].”
BackgroundSelf-citationThe Mammalian Tribbles Homolog TRIB3, Glucose Homeostasis, and Cardiovascular Diseases
Prudente, S., Sesti, G., Pandolfi, A., Andreozzi, F., Consoli, A., & Trischitta, V. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1042 · Cited by 124
“(47), for instance, demonstrated that in mice with PPAR- coactivator-1 (PGC-1) hepatic deficiency, 6 Prudente et al.”
BackgroundBurgess, S. C., Leone, T. C., Wende, A. R., Croce, M. A., Chen, Z., Sherry, A. D., Malloy, C. R., & Finck, B. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600050200 · Cited by 111
Iershov, A., Nemazanyy, I., Alkhoury, C., Girard, M., Barth, E., Cagnard, N., Montagner, A., Chretien, D., Rugarli, E. I., Guillou, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09598-9 · Cited by 109
TRB3 suppresses adipocyte differentiation by negatively regulating PPARγ transcriptional activity
Takahashi, Y., Ohoka, N., Hayashi, H., & Sato, R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700545-jlr200 · Cited by 107
“Because TRB3 gene expression is induced during differentiation and it has been reported that the TRB3 promoter contains a PPRE and is activated by PPARa in the liver ( 29 ), we next examined whether TRB3 gene expression in adipocytes is augmented by PPARg, a member of the PPAR family expressed exclusively in adipocyte…”
BackgroundBernal‐Mizrachi, C., Xiaozhong, L., Li, Y., Knutsen, R. H., Howard, M. J., Arends, J. J. A., DeSantis, P., Coleman, T., & Semenkovich, C. F. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2006.12.010 · Cited by 115
“PPARα activation promotes fatty acid oxidation (Reddy, 2001), ketogenesis (Rodriguez et al., 1994), and gluconeogenesis (Bernal-Mizrachi et al., 2003;Koo et al., 2004;Patsouris et al., 2004).”
BackgroundThe biology of PGC-1α and its therapeutic potential
Handschin, C. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.006 · Cited by 108
Prudente, S., Hribal, M. L., Flex, E., Turchi, F., Morini, E., Cosmo, S. D., Bacci, S., Tassi, V., Cardellini, M., Lauro, R., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2807 · Cited by 107
He, L., Simmen, F. A., Mehendale, H. M., Ronis, M. J. J., & Badger, T. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510724200 · Cited by 105
Role of PPAR in Hepatic Carbohydrate Metabolism
Peeters, A., & Baes, M. (2010) · PPAR Research · doi:10.1155/2010/572405 · Cited by 101
“During fasting and upon WY14643 treatment, hepatic expression of TRB3 was induced in wild type, but not in PPARα−/− mice [57].”
BackgroundMisu, H., Takamura, T., Matsuzawa, N., Shimizu, A., Ota, T., Sakurai, M., Ando, H., Arai, K., Yamashita, T., Honda, M., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0489-8 · Cited by 102
“Contrary to the decrease of PPARGC1A expression in the skeletal muscle of patients with type 2 diabetes, PPARGC1A expression in the liver has been shown to be elevated in animal models of diabetes [8–11].”
BackgroundMortensen, O. H., Frandsen, L., Schjerling, P., Nishimura, E., & Grunnet, N. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00591.2005 · Cited by 101
“PGC-1 and to some extent PGC-1 overexpression in the skeletal muscle cell cultures caused an increase in TRB3 mRNA (Fig. 3) in accordance with the observation that TRB3 upregulation in liver is caused by PGC-1 ( 22 ).”
BackgroundHic-5 regulates an epithelial program mediated by PPARγ
Drori, S., Girnun, G. D., Tou, L., Szwaya, J. D., Mueller, E., Kia, X., Shivdasani, R. A., & Spiegelman, B. M. (2005) · Genes & Development · doi:10.1101/gad.1240705 · Cited by 102
“Toagain evaluate the specificity of these effects, Moser cells were infected with either adenovirus expressing siRNA targeted against PGC1-(cid:2) (siRNA-(cid:2) ) (Koo et al. 2004), or a scrambled oligonucleotide, and treated with or without rosiglitazone.”
Tribbles: novel regulators of cell function; evolutionary aspects
Hegedüs, Z., Czibula, Á., & Kiss‐Toth, E. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6007-9 · Cited by 101
Kokil, G. R., Veedu, R. N., Ramm, G. A., Prins, J. B., & Parekh, H. S. (2015) · Chemical Reviews · doi:10.1021/cr5002832 · Cited by 111
Cooper, M. P., Qu, L., Rohas, L. M., Lin, J., Yang, W., Erdjument-Bromage, H., Tempst, P., & Spiegelman, B. M. (2006) · Genes & Development · doi:10.1101/gad.1483906 · Cited by 100
“PGC-1 (cid:1) is both necessary and sufficient to drive gluconeogenic gene expression (Yoon et al. 2001; Puigserver et al. 2003; Koo et al. 2004; Lin et al. 2004), and PGC-1 (cid:1) is regulated by the transcription factor CREB in a fasting-dependent manner (Herzig et al. 2001).”
BackgroundHuang, J., Viswakarma, N., Yu, S., Jia, Y., Bai, L., Vluggens, A., Cherkaoui‐Malki, M., Khan, M., Singh, I., Yang, G., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.030 · Cited by 106
Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor
Savkur, R. S., Bramlett, K. S., Michael, L. F., & Burris, T. P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.141 · Cited by 103
Kumashiro, N., Tamura, Y., Uchida, T., Ogihara, T., Fujitani, Y., Hirose, T., Mochizuki, H., Kawamori, R., & Watada, H. (2008) · Diabetes · doi:10.2337/db08-0144 · Cited by 94
Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice
Zheng, Y., Liu, T., Wang, Z., Xu, Y., Zhang, Q., & Luo, D. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.02.072 · Cited by 98
Estrogen-related Receptor α Is a Repressor of Phosphoenolpyruvate Carboxykinase Gene Transcription
Herzog, B., Cardenas, J., Hall, R. K., Villena, J. A., Budge, P. J., Giguère, V., Granner, D. K., & Kralli, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509276200 · Cited by 87
Gender-Specific Response to Isoflurane Preconditioning in Focal Cerebral Ischemia
Kitano, H., Young, J. M., Cheng, J., Wang, L., Hurn, P. D., & Murphy, S. J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600444 · Cited by 96
Yazawa, T., Inaoka, Y., Okada, R., Mizutani, T., Yamazaki, Y., Usami, Y., Kuribayashi, M., Orisaka, M., Umezawa, A., & Miyamoto, K. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0352 · Cited by 91
Gupta, P., Bala, M., Gupta, S. K., Dua, A., Dabur, R., Injeti, E. R., & Mittal, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.029 · Cited by 101
Bort, A., Sánchez, B. G., Mateos‐Gómez, P. A., Díaz‐Laviada, I., & Rodríguez‐Henche, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071660 · Cited by 96
Targeting Mitochondria in Diabetes
Jakovljevic, N. K., Pavlović, K., Jotić, A., Lalic, K. S., Stoiljkovic, M. M., Lukić, L., Milicic, T. J., Macesic, M. V., Gajović, J. S., & Lalic, N. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126642 · Cited by 105
“PGC-1α deficient mice showed improved hepatic insulin sensitivity [48].”
BackgroundHu, P., Li, K., Peng, X., Kan, Y., Li, H., Zhu, Y., Wang, Z., Li, Z., Liu, H., & Cai, D. (2023) · Nutrients · doi:10.3390/nu15224772 · Cited by 97
“An existing study has shown that in mice, the deficiency of Atgl(patatin-like phospholipase domain containing 2) induces a decrease in the mRNA levels of PPAR-α , leading to reduced expression of PGC-1 α and severe impairment of mitochondrial substrate oxidation and respiration [42].”
BackgroundWang, X.-A., Zhang, R., Jiang, D., Deng, W., Zhang, S., Deng, S., Zhong, J., Wang, T., Zhu, L.-H., Yang, L., et al. (2013) · Hepatology · doi:10.1002/hep.26368 · Cited by 90
Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response
Wennemers, M., Bussink, J., Scheijen, B., Nagtegaal, I. D., van Laarhoven, H. W. M., Raleigh, J. A., Varia, M. A., Heuvel, J. J. T. M., Rouschop, K. M. A., Sweep, F. C. G. J., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2934 · Cited by 99
“Furthermore, TRIB3 has a role in insulin sensitivity and diabetes [10,42-44] and has also been described to interact as a scaffold protein in multiple signaling cascades, including v-akt murine thymoma viral oncogene homolog 1 (PKB/Akt) [10,13] but also MAPK [11] pathways.”
BackgroundSystem-based approaches to decode the molecular links in Parkinson's disease and diabetes
Santiago, J. A., & Potashkin, J. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.019 · Cited by 95
Lai, L., Wang, M., Martin, O. J., Leone, T. C., Vega, R. B., Han, X., & Kelly, D. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.523654 · Cited by 86
“The adenoviral shRNA vectors Ad-shPGC-1 and Ad-shPGC-1 have been described previously (23, 24).”
MethodPartnership of PGC-1α and HNF4α in the Regulation of Lipoprotein Metabolism
Rhee, J., Ge, H., Yang, W., Fan, M., Handschin, C., Cooper, M., Lin, J., Li, C., & Spiegelman, B. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512636200 · Cited by 86
TRB3 protects cells against the growth inhibitory and cytotoxic effect of ATF4
Örd, D., Meerits, K., & Örd, T. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.017 · Cited by 88
TORC2 Regulates Hepatic Insulin Signaling via a Mammalian Phosphatidic Acid Phosphatase, LIPIN1
Ryu, D., Oh, K., Jo, H.-Y., Hedrick, S. A., Kim, Y.-N., Hwang, Y.-J., Park, T., Han, J., Choi, C. S., Montminy, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.007 · Cited by 91
“For GTT, mice were fasted for 16 hr and then injected intraperitoneally with 1 g/kg (for db/db mice) or 2 g/kg (for C57BL/6 mice) body weight of glucose (Koo et al., 2004).”
MethodSelf-citationLoss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation
Salazar‐Roa, M., Lorente, M., García-Taboada, E., Pérez-Gómez, E., Dávila, D., Zúñiga-García, P., Flores, J. M., Rodríguez, A., Hegedüs, Z., Mosén-Ansorena, D., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.133 · Cited by 88
Insulin signaling regulating genes: effect on T2DM and cardiovascular risk
Prudente, S., Morini, E., & Trischitta, V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.215 · Cited by 93
“The Q84r polymorphism of TRIB3 The mammalian kinase TRIB3 (also known as TRB3/NIPK) has been reported by most”
BackgroundMorse, E., Schroth, J., You, Y.-H., Pizzo, D. P., Okada, S., RamachandraRao, S., Vallon, V., Sharma, K., & Cunard, R. A. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00236.2010 · Cited by 96
TRB3 Blocks Adipocyte Differentiation through the Inhibition of C/EBPβ Transcriptional Activity
Bezy, O., Vernochet, C., Gesta, S., Farmer, S. R., & Kahn, C. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00375-07 · Cited by 88
“Overexpression of TRB3 in liver completely inhibits insulin-stimulated S6 kinase 1 (S6K1) activation by mammalian target of rapamycin (mTOR), while knockdown of endogenous TRB3 increases both basal and insulin-stimulated activity ( 28 ).”
BackgroundPGC-1s in the Spotlight with Parkinson’s Disease
Piccinin, E., Sardanelli, A. M., Seibel, P., Moschetta, A., Cocco, T., & Villani, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073487 · Cited by 87
Oh, K.-J., Park, J., Kim, S. S., Oh, H., Choi, C. S., & Koo, S.-H. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002986 · Cited by 83
“Western blot analyses of whole-cell extracts were performed as described [53].”
MethodSelf-citationKim, D., Kim, J. R., Koh, M., Kim, Y. D., Lee, J.-M., Chanda, D., Park, S. B., Min, J., Lee, C., Park, T., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.250613 · Cited by 90
Self-citationAbnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis
Miyoshi, N., Ishii, H., Mimori, K., Takatsuno, Y., Kim, H., Hirose, H., Sekimoto, M., Doki, Y., & Mori, M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605361 · Cited by 87
“…101, 1664 – 1670 & 2009 Cancer Research UK All rights reserved 0007 – 0920/09 $32.00 www.bjcancer.com C lin ic a l S tu d ie s 2003; Du et al, 2003; Koo et al, 2004; Boudeau et al, 2006; He et al, 2006; Koh et al, 2006; Matsushima et al, 2006; Ord et al, 2007; Kato and Du, 2007; Xu et al,…”
InfluentialMetabolic roles of PGC-1α and its implications for type 2 diabetes
Besseiche, A., Riveline, J., Gautier, J., Bréant, B., & Blondeau, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.002 · Cited by 97
“Finally, in genetic odels of insulin resistance and T2D, PGC-1 is induced in the iver [109,110].”
BackgroundChoi, D., Oh, K.-J., Han, H.-S., Yoon, Y.-S., Jung, C.-Y., Kim, S.-T., & Koo, S.-H. (2012) · Hepatology · doi:10.1002/hep.25809 · Cited by 81
Self-citationGali Ramamoorthy, T., Laverny, G., Schlagowski, A.-I., Zoll, J., Messaddeq, N., Bornert, J.-M., Panza, S., Ferry, A., Geny, B., & Metzger, D. (2015) · Nature Communications · doi:10.1038/ncomms10210 · Cited by 74
“A 15-kb-targeting vector, encompassing PGC-1 b exons 4–6 in which exon 5 encoding one of the three NR boxes of the nuclear receptor interacting domain was flanked by LoxP sites, was PCR generated (Fig.”
Vanin-1 Is a Key Activator for Hepatic Gluconeogenesis
Chen, S., Zhang, W., Tang, C., Tang, X., Liu, L., & Liu, C. (2014) · Diabetes · doi:10.2337/db13-0788 · Cited by 88
Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity
Liang, H., Balas, B., Tantiwong, P., Dube, J., Goodpaster, B. H., O'Doherty, R. M., DeFronzo, R. A., Richardson, A., Musi, N., & Ward, W. F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90292.2008 · Cited by 81
The Roles of Peroxisome Proliferator-Activated Receptors in the Metabolic Syndrome
Mansour, M. M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00007-7 · Cited by 83
Transcriptional regulators of hepatic gluconeogenesis
Oh, K., Han, H.-S., Kim, M.-J., & Koo, S. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0018-5 · Cited by 85
Self-citationNdiaye, K., Fayad, T., Silversides, D. W., Sirois, J., & Lussier, J. G. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.104.038026 · Cited by 88
Timmons, J. A., Norrbom, J., Schéele, C., Thonberg, H., Wahlestedt, C., & Tesch, P. (2006) · Genomics · doi:10.1016/j.ygeno.2005.09.007 · Cited by 79
“For example, it transpires that increased PGC-1a activity may contribute to the failure of insulin to suppress postprandial hepatic glucose output [11], while PGC-1a expression also appears to be elevated, not suppressed, in glucose-insensitive pancreatic h cells—actively contributing to impaired insulin secretion [31…”
BackgroundYoon, Y.-S., Lee, M., Ryu, D., Kim, J. H., Ma, H., Seo, W., Kim, Y.-N., Kim, S. S., Lee, C. H., Hunter, T. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012665107 · Cited by 80
Self-citationTranscriptional Regulation of Hepatic Fatty Acid Metabolism
Guillou, H., Martin, P. G. P., & Pineau, T. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_1 · Cited by 90
Okamoto, H., Latres, E., Liu, R., Thabet, K., Murphy, A., Valenzeula, D., Yancopoulos, G. D., Stitt, T. N., Glass, D. J., & Sleeman, M. W. (2007) · Diabetes · doi:10.2337/db06-1448 · Cited by 79
The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase
Erazo, T., Lorente, M., López-Plana, A., Muñoz-Guardiola, P., Fernández-Nogueira, P., García-Martínez, J. A., Bragado, P., Fuster, G., Salazar, M., Espadaler, J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1808 · Cited by 76
The potential for phospholipase D as a new therapeutic target
Huang, P. C., & Frohman, M. A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.707 · Cited by 82
“Different kinds of strategies have been developed for systemic delivery of siRNA-based drugs, such as adenovirus-mediated gene silencing in liver [121,122], high pressure injection (hydrodynamic) of siRNAs, encapsulating the siRNA in microparticles or liposomes [123,124] and, more recently, binding siRNA to protamine-…”
BackgroundHsieh, Y., Choudhry, M. A., Huang-Ping, Y., Shimizu, T., Yang, S., Suzuki, T., Chen, J., Bland, K. I., & Chaudry, I. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-5549com · Cited by 86
The emerging roles of lipids in circadian control
Adamovich, Y., Aviram, R., & Asher, G. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.013 · Cited by 85
Kim, D., Gang, G., Ryu, D., Koh, M., Kim, Y.-N., Kim, S. S., Park, J., Kim, Y., Sim, T., Lee, I., et al. (2013) · Diabetes · doi:10.2337/db12-0946 · Cited by 79
Self-citationWood, J. R., Nelson-Degrave, V. L., Jansen, E., McAllister, J. M., Mosselman, S., & Strauss, J. F. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00193.2004 · Cited by 78
Enhanced TLR-mediated NF-IL6–dependent gene expression by Trib1 deficiency
Yamamoto, M., Uematsu, S., Okamoto, T., Matsuura, Y., Sato, S., Kumar, H., Satoh, T., Saitoh, T., Takeda, K., Ishii, K. J., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070183 · Cited by 77
5-Hydroxytryptamine Receptor Stimulation of Mitochondrial Biogenesis
Rasbach, K. A., Funk, J. A., Jayavelu, T., Green, P. T., & Schnellmann, R. G. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.159947 · Cited by 77
“PGC-1 RNAi plasmid was a generous gift from Marc Montminy (Salk Institute for Biological Studies, San Diego, CA) (Koo et al., 2004).”
MethodDeng, J., Liu, Y., Duan, Z., Zhu, C., Hui, J., Mi, Y., Ma, P., Ma, X., Fan, D., & Yang, H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00506 · Cited by 77
“Downregulation of PGC1α, PECPK, and G6Pase in the liver improves hepatic insulin sensitivity and inhibition of hepatic glucose production in db/db mice (Koo et al., 2004).”
BackgroundYoneda, M., Hotta, K., Nozaki, Y., Endo, H., Uchiyama, T., Mawatari, H., Iida, H., Kato, S., Hosono, K., Fujita, K., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-27 · Cited by 80
“Recent evidence also implicates PPARGC1A in the homeostatic control of systemic energy metabolism, and PPARGC1A has been shown to regulate several key hepatic gluconeogenic genes [ 31-34 ].”
BackgroundHIV-1 Vpr Induces Adipose Dysfunction in Vivo Through Reciprocal Effects on PPAR/GR Co-Regulation
Agarwal, N., Iyer, D., Patel, S. G., Sekhar, R. V., Phillips, T. M., Schubert, U., Oplt, T., Buras, E. D., Samson, S. L., Couturier, J. P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007148 · Cited by 78
Metadata
- Authors
- Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M.
- Affiliations
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Montminy, Marc
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-04-25
- Volume
- 10
- Issue
- 5
- Pages
- 530-534
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1603786143
- Cited by
- 550
- References
- 28
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 15 · 2021: 19 · 2020: 19 · 2019: 13 · 2018: 22 · 2017: 20 · 2016: 21 · 2015: 22 · 2014: 34 · 2013: 31 · 2012: 31
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM037828, GM R01 37828)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- PGC-1, insulin resistance, PPARα, type 2 diabetes, hepatic insulin sensitivity, glucose tolerance, Akt signaling, fasting hypoglycemia, nuclear receptors, hepatic gluconeogenesis, RNAi knockdown
- MeSH terms
- Animals, Base Sequence, Diabetes Mellitus, Type 2, DNA, Humans, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Transcription Factors, Signal Transduction, Rats, Wistar, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Cell Cycle Proteins, RNA Interference, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.